Mark F. Munsell, MS
Sr Research Statistician
The University of Texas MD Anderson Cancer Center
1400 Hermann Pressler Drive
Houston,
TX
USA
77030
Papers:
192
Phase II trial of bevacizumab with carboplatin and dose-dense paclitaxel as first-line treatment in patients with advanced ovarian cancer
396
Platinum-free interval is a predictor of survival for recurrent, advanced stage uterine papillary serous carcinoma
450
Paraneoplastic neurologic syndrome in ovarian carcinoma
490
Symptom burden in women with advanced or recurrent cervical cancer referred to a supportive care center
Adenocarcinoma in situ (AIS) of the cervix: Is Loop Electrosurgical Excision Procedure (LEEP) an acceptable alternative to Cold Knife Cone Biopsy?
Management of Stage II Endometrial Cancer: Is Radical Hysterectomy Necessary?